论文信息 - Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions. - 字舞流文

Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.

J. Morales | J. Campistol | M. Arias | J. Ruiz | A. Mota | D. Prats | J. Gutiérrez | J. Garcia | A. Castro | J. M. Grynió | J. M. Gómez | J. Garcia

[1] J. Morales,et al. Early cyclosporine a withdrawal in kidney transplant recipients under a sirolimus-based immunosuppressive regimen: pathological study of graft biopsies at 1-year posttransplant. , 2002, Transplantation proceedings.

[2] R. Oberbauer,et al. Sirolimus Allows Early Cyclosporine Withdrawal in Renal Transplantation Resulting in Improved Renal Function and Lower Blood Pressure. , 2001 .

[3] J. Squifflet,et al. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. , 2000, Transplantation.

[4] L. Paul. Chronic allograft nephropathy: An update. , 1999, Kidney international.

[5] R. Calne,et al. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. , 1999, Transplantation.

[6] F. Vincenti,et al. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine , 1998 .

[7] A. S. Wiener,et al. Transplantation , 1963 .